Skip to Content
 

News: Prostate Cancer

Study examines prostate cancer treatment decisions

Thursday, January 2nd, 2020

A five-year follow-up study of U.S. men who received prostate cancer treatment is creating a road map for future patients to clarify expectations and enable men to make informed choices about care.

Research summit to highlight genitourinary cancer advances

Thursday, October 24th, 2019

Some of the nation’s leading genitourinary cancer physicians will speak about the latest advances in care at an OncLive State of the Science Summit held in collaboration with Vanderbilt-Ingram Cancer Center.

Potential prostate cancer biomarkers

Thursday, September 19th, 2019

An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.

New prostate cancer treatment concept

Friday, August 30th, 2019

Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.

Hand-held robot points to less invasive prostate surgery

Friday, July 19th, 2019

Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.

Pathways of radiosensitization

Thursday, April 25th, 2019

Austin Kirschner, MD, PhD, and colleagues have studied the mechanism of radiation sensitization for enzalutamide using multiple models of human prostate cancer.

VISE team seeks to develop new robot to ease prostatectomies

Thursday, April 25th, 2019

The Vanderbilt Institute for Surgery and Engineering (VISE) team of Robert Webster III, PhD, and Duke Herrell, MD, have received a $2.2 million grant from the National Institutes of Health to develop a new surgical robot for endoscopic transurethral prostatectomy.

Tool guides decision-making for prostate cancer patients

Thursday, April 4th, 2019

Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.

Therapy aims to reduce prostate cancer treatment side effects

Friday, December 14th, 2018

Vanderbilt urologic surgeons are offering an alternative therapy for prostate cancer patients considered to be low-to-intermediate risk, a middle ground between active surveillance and aggressive therapy.

Men: What to ask your doctor about prostate cancer screening

Friday, July 6th, 2018

Making sense of the updated guidelines for prostate cancer screening.

Next Page »